Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomised Placebo-controlled Trial of Anti-ST2 in COPD (COPD-ST2OP)

Next Previous
Trial Profile

A Randomised Placebo-controlled Trial of Anti-ST2 in COPD (COPD-ST2OP)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Nov 2018

At a glance

  • Drugs RG 6149 (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Acronyms COPD-ST2OP

    • Most Recent Events

    • 31 Oct 2018 Planned End Date changed from 30 Jun 2020 to 31 Aug 2020.
    • 31 Oct 2018 Planned primary completion date changed from 31 Mar 2019 to 30 Apr 2020.
    • 31 Oct 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top